Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio”), a specialty pharmaceutical company offering differentiated products to patients, and Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) (“Spectrum”), a commercial stage biopharmaceutical company focused on novel and targeted oncology, announced that they have entered into a definitive agreement pursuant to which Assertio will acquire all outstanding shares of Spectrum in an all-stock and contingent value rights (“CVR”) transaction.
Read the full article: Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction //
Source: https://www.globenewswire.com/news-release/2023/04/25/2653629/0/en/Assertio-Holdings-Inc-to-Acquire-Spectrum-Pharmaceuticals-Inc-in-All-Stock-and-CVR-Transaction.html